FDA’s Proposal to Remove Oral Phenylephrine from the OTC Monograph Isn’t a Surprise but What is Left “Over-the-Counter”?
The FDA Law Blog
NOVEMBER 11, 2024
As those of us of a certain age remember, prior to 2005/2006, pseudoephedrine was the decongestant of choice for OTC multi-symptom cold medicine. Then, Congress passed, and the President signed the Combat Methamphetamine Epidemic Act of 2005. a); OTC Monograph M012: § M012.20. a); OTC Monograph M012: § M012.20.
Let's personalize your content